Immunopathology: Evaluation from Discovery to Safety Assessment |
|
Enduring |
|
$25.00 |
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
TDAR assessments |
|
Enduring |
|
$25.00 |
Nonclinical Development of Biologics |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Basic principles of toxicology, toxicology of the immune system, relevance to immunosafety |
|
Enduring |
|
$25.00 |
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity |
|
Enduring |
|
$25.00 |
CAR Therapy |
|
Enduring |
|
$25.00 |
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
Cytokine Release Syndrome (CRS) |
|
Enduring |
|
$25.00 |
CD3-binding (T cell engaging) immune stimulating antibody-based therapies |
|
Enduring |
|
$25.00 |
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |